Letter from European Commission, Europien Medicines Agency and Head of Medicines Agencies regarding the implementation of safety features

LZVO republishes Letter to stakeholders regarding the implementation of safety features under the Falsified Medicines Directive 2011/62/EU.

Letter issued by the European Commission underlining the legal obligations which will apply from the 9^th of February to the different stakeholders. The Commission is very clear: “It is important that all stakeholders act now to ensure compliance with the new rules whilst there is still sufficient time to prepare.”

Read letter online: https://ec.europa.eu/health/sites/health/files/files/falsified_medicines/2018_letterstakeholders_safetyfeatures_en.pdf